Amersham Pharmacia gets order for MegaBACE:
This article was originally published in Clinica
Nycomed Amersham's life science division, Amersham Pharmacia Biotech, has received a boost in the form of an order for a further 60 of its MegaBACE 1000 high throughput DNA sequencers from the Joint Genome Institute. The institute placed an initial order for 26 devices in June. Sales of Amersham Pharmacia Biotech's product had slumped during the half year because of the launch of a new product by competitor Perkin-Elmer in March.